The Solution and Solid State Stability and Excipient Compatibility of Parthenolide in Feverfew

被引:49
作者
Jin, Ping [1 ]
Madieh, Shadi [1 ]
Augsburger, Larry L. [1 ]
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
关键词
Feverfew; Botanical; Parthenolide; Stability; Excipient compatibility;
D O I
10.1208/pt0804105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objectives of this research were to evaluate the stability of parthenolide in feverfew solution state and powdered feverfew (solid state), and explore the compatibility between commonly used excipients and parthenolide in feverfew. Feverfew extract solution was diluted with different pH buffers to study the solution stability of parthenolide in feverfew. Powdered feverfew extract was stored under 40 degrees C/0%similar to 75% relative humidities (RH) or 31% RH/5 similar to 50 degrees C to study the influence of temperature and relative humidity on the stability of parthenolide in feverfew solid state. Binary mixtures of feverfew powered extract and different excipients were stored at 50 degrees C/75% RH for excipient compatibility evaluation. The degradation of parthenolide in feverfew solution appears to fit a typical first-order reaction. Parthenolide is comparatively stable when the environmental pH is in the range of 5 to 7, becoming unstable when pH is less than 3 or more than 7. Parthenolide degradation in feverfew in the solid state does not fit any obvious reaction model. Moisture content and temperature both play important roles affecting the degradation rate. After 6 months of storage, parthenolide in feverfew remains constant at 5 degrees C/31% RH. However, similar to 40% parthenolide in feverfew can be degraded if stored at 50 degrees C/31% RH. When the moisture changed from 0% to 75% RH, the degradation of parthenolide in feverfew increased from 18% to 32% after 6-month storage under 40 degrees C. Parthenolide in feverfew exhibits good compatibility with commonly used excipients under stressed conditions in a 3-week screening study.
引用
收藏
页数:6
相关论文
共 18 条
[1]  
Abourashed EA, 2000, J AOAC INT, V83, P789
[2]  
[Anonymous], STAB TEST NEW DRUG S
[3]   BIOMIMETIC TRANSFORMATIONS OF PARTHENOLIDE [J].
CASTANEDAACOSTA, J ;
FISCHER, NH ;
VARGAS, D .
JOURNAL OF NATURAL PRODUCTS, 1993, 56 (01) :90-98
[4]  
Draves AH, 2004, CAN PHARM J, V136, P23
[5]   The content of parthenolide and its yield per plant during the growth of Tanacetum parthenium [J].
Hendriks, H ;
AndersonWildeboer, Y ;
Engels, G ;
Bos, R ;
Woerdenbag, HJ .
PLANTA MEDICA, 1997, 63 (04) :356-359
[6]   PARTHENOLIDE CONTENT AND BIOACTIVITY OF FEVERFEW (TANACETUM-PARTHENIUM (L) SCHULTZ-BIP) - ESTIMATION OF COMMERCIAL AND AUTHENTICATED FEVERFEW PRODUCTS [J].
HEPTINSTALL, S ;
AWANG, DVC ;
DAWSON, BA ;
KINDACK, D ;
KNIGHT, DW ;
MAY, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (05) :391-395
[7]  
JIN P, AAPS PHARMS IN PRESS
[8]  
Kaplan M, 2002, TURK J CHEM, V26, P473
[9]  
KEMPER KJ, FEVERFEW TANACETUM P
[10]   Excipient compatibility study of Hypericum perforatum extract (St. John's Wort) using similarity metrics to track phytochemical profile changes [J].
Kopelman, SH ;
Augsburger, LL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :35-46